llca

International Liver Cancer Association (ILCA) announces 10th annual conferece

This year, ILCA celebrates, promoting novel pathogenic, diagnostic and therapeutic interventions for liver cancer at Conference.

Brussels, Belgium – The International Liver Cancer Association (ILCA) announces its 10th ILCA Annual Conference, which will take place on 9-11 September in Vancouver, Canada.

[pullquote]

“It is my hope that we continue to grow as an organisation and see more primary data presented at the Annual Meeting. ILCA should become the place to present results. It will happen as we continue to get an even greater turn out at the meeting from all disciplines; from basic scientists to clinical trialists. The ILCA Governing Board has international representation and is multi-specialty.”

— Richard Finn (USA), ILCA President 2015-2017

[/pullquote]

This year’s meeting is very special as it marks the 10th Anniversary of ILCA. For the past 10 years, ILCA has been significantly contributing to advancing liver cancer science, consistently focusing on its mission to promote novel pathogenic, diagnostic and therapeutic interventions for liver cancer by taking a transversal approach to research and bringing together scientists, physicians and allied professionals from all interrelated fields.

Since its creation, ILCA has brought together the most eminent liver cancer experts from all around the globe around this common scientific purpose, with the ultimate goal to improve prevention, diagnosis, treatment and care of patients. The disease is heavily impacting public health globally, and ILCA is now established as one of the most significant contributors to liver cancer science.

This year again ILCA has prepared a programme featuring multidisciplinary and transversal insights, with the objective to encourage and stimulate scientific debate and networking between liver cancer experts from all regions.

This year’s ILCA Annual Meeting will attract as many as 600 hepatologists, gastroenterologists, oncologists, basic researchers, pathologists, surgeons and allied professionals across liver cancer related disciplines to exchange on their findings, experiences and best practices.

290 abstracts were accepted to the ILCA Annual Meeting, the vast majority of which will be publicly made available at ilca2016.org in August 2016.